Robeauté
Robeauté is pioneering a new class of therapeutic microrobots designed to diagnose, treat, and monitor the brain with unprecedented flexibility and precision. Combining robotics, physics, material science, chemistry, biology, and medicine, the company aims to revolutionize neurosurgery with modular medical devices that can adapt to various clinical applications, from tissue sampling to targeted therapies and real-time data collection from deep within the brain.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Therapeutic microrobot platform for intracerebral applications
A modular microrobotic device platform designed to perform tissue sampling, targeted therapy delivery, electrode implantation and real-time data collection within the brain using interchangeable micro-extensions.
Therapeutic microrobot platform for intracerebral applications
A modular microrobotic device platform designed to perform tissue sampling, targeted therapy delivery, electrode implantation and real-time data collection within the brain using interchangeable micro-extensions.
Services
Partnerships with clinical and research groups to develop and translate microrobotic tools for intracerebral applications.
Partnerships with clinical and research groups to develop and translate microrobotic tools for intracerebral applications.
Expertise Areas
- Microrobotics design and engineering
- Intracerebral access and navigation
- Targeted neurosurgical therapeutic delivery
- Micro-scale tissue sampling and diagnostics
Key Technologies
- Microrobotics
- Modular robotic platforms
- Micro-scale navigation
- Targeted drug delivery
News & Updates
Robeauté’s microrobots can enter the brain to diagnose, treat and monitor neurological conditions in a way that was previously impossible
Robeauté, a start-up which promises to transform brain surgeries with microrobots the size of a grain of rice, has raised $28 million in its latest funding round. Co-founder and COO Joana Cartocci spoke to Bloomberg's Tom Mackenzie about the challen
Bertrand Duplat, left, and Joana Cortocci are the two cofounders of Robeauté, a Paris-based startup developing a microrobot that can travel inside the human brain to assist in surgical procedures. The company just secured an additional $28 million in
Coup de cœur du jury at Paris Saclay Cancer Cluster Innovation Forum
1st place at 13th MEDICA Start-up competition
Selected for Medtech Innovator Cohort
Robeauté’s microrobots can enter the brain to diagnose, treat and monitor neurological conditions in a way that was previously impossible
Robeauté, a start-up which promises to transform brain surgeries with microrobots the size of a grain of rice, has raised $28 million in its latest funding round. Co-founder and COO Joana Cartocci spoke to Bloomberg's Tom Mackenzie about the challen
Bertrand Duplat, left, and Joana Cortocci are the two cofounders of Robeauté, a Paris-based startup developing a microrobot that can travel inside the human brain to assist in surgical procedures. The company just secured an additional $28 million in